Oct 19, 2015
2:125
For every 125 shares held, investors received 2. The price per share adjusted from $0.06 to $0.00.
The split itself did not change the total investment value.
Evolutionary Genomics, Inc. (FNAM) trades on the Other OTC in the Biotechnology industry.
Evolutionary Genomics, Inc. company overviewThe latest split shown was on October 19, 2015. It was a 2-for-125 reverse split, so shareholders received 2 shares for every 125 they held.
This history records one reverse split, on October 19, 2015.